The Zacks Analyst Blog Highlights: JPMorgan, Walmart, PayPal, Equinix and Boston Scientific – Entrepreneur

Signing out of account, Standby…
The Zacks Analyst Blog Highlights: JPMorgan, Walmart, PayPal, Equinix and Boston Scientific
Chicago, IL – December 22, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: JPMorgan Chase & Co. JPM, Walmart Inc. WMT, PayPal Holdings, Inc. PYPL, Equinix, Inc. EQIX and Boston Scientific Corporation BSX.
The Zacks Research Daily presents the best research output of our analyst team. Today’s Research Daily features new research reports on 16 major stocks, including JPMorgan, Walmart, and PayPal. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Shares of JPMorgan have underperformed the Zacks Major Regional Banks industry over the past year (+29.7% vs. +36%), however, things seem to be improving. The Zacks analyst believes that JPMorgan’s business diversification efforts, strategic add-on acquisitions, and initiatives to expand the branch network in new markets are some of the major tailwinds.
Digitization initiatives and strength in the mortgage banking business are expected to further support JPM’s financials. A robust investment banking pipeline is also likely to aid revenues. Low interest rates in the near term, however, are expected to keep hurting JPMorgan’s margins and interest income. Normalization of the trading business remains another major concern.
(You can read the full research report on JPMorgan here >>>)
Walmart shares have lost -1.9% in the year to date period against the Zacks Supermarkets industry’s gain of +0.7%. However, things are not all that bad. The Zacks analyst believes that Walmart has been gaining from its sturdy comp sales record, driven by its constant omnichannel efforts. WMT has been posting positive comp sales in the U.S. division for the past 29 quarters.
A strong inventory position, increased contributions from advertising revenues and lower markdowns have somewhat helped WMT counter inflationary pressures. With more customers and members returning to stores and clubs, demand is expected to remain strong. Supply chain and labor market woes, however, are likely to weigh on the company’s margins.
(You can read the full research report on Walmart here >>>)
Shares of PayPal have gained +2.9% in the last six months against the Zacks Internet Software industry’s loss of -10%. The Zacks analyst believes that Paypal has been benefiting from robust growth in total payments volume owing to increasing net new active accounts.
Venmo’s improving monetization efforts and rising adoption rate across various platforms have been aiding the total active accounts growth. Solid momentum of core peer to peer and PayPal Checkout experiences is another tailwind. Accelerating transaction revenues are also likely to continue driving revenues. Intensifying competition in the digital payment market, however, remains a major concern.
(You can read the full research report on PayPal here >>>)
Other noteworthy reports we are featuring today include Equinix and Boston Scientific.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com                                      
https://www.zacks.com                                          
 
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

 

JPMorgan Chase & Co. (JPM): Free Stock Analysis Report

 

Boston Scientific Corporation (BSX): Free Stock Analysis Report

 

Equinix, Inc. (EQIX): Free Stock Analysis Report

 

Walmart Inc. (WMT): Free Stock Analysis Report

 

PayPal Holdings, Inc. (PYPL): Free Stock Analysis Report

 

To read this article on Zacks.com click here.

 

Zacks Investment Research
Swayta Shah
Zacks Equity Research
Zacks Equity Research
Successfully copied link

source

Leave a Reply

Your email address will not be published.